Pluvicto теперь одобрен при гормоночувствительном #РакПростаты? | #MarkScholzMD #AlexScholz #PCRI

To learn more about prostate cancer, visit http://www.pcri.org 00:00 Introduction 00:30 What is Pluvicto and how does it work? 01:15 Do non-hormone-resistant patients on Pluvicto need hormone therapy? 01:48 Do patients on Pluvicto need to try a specific generation of hormone therapy? 02:57 Is chemotherapy still a prerequisite for starting Pluvicto? 03:30 How successful is Pluvicto at controlling prostate cancer? 04:59 Do any hormone therapies combine poorly with pluvicto? 06:07 What is the goal of combining Pluvicto and hormone therapy? 07:53 What quality of life impacts could this combination therapy have? 09:18 Alex's conclusions Don't know your stage? Take the quiz: visit http://www.prostatecancerstaging.org Sign up for our newsletter here to receive the latest updates on prostate cancer and the PCRI: https://pcri.org/join Who we are: The Prostate Cancer Research Institute (PCRI) is a 501(c)(3) not-for-profit organization that is dedicated to helping you research your treatment options. We understand that you have many questions, and we can help you find the answers that are specific to your case. All of our resources are designed by a multidisciplinary team of advocates and expert physicians for patients. We believe that by educating yourself about the disease, you will have more productive interactions with your medical professionals and receive better-individualized care. Feel free to explore our website at pcri.org or contact our free helpline with any questions that you have at pcri.org/helpline. Our Federal Tax ID # is 95-4617875 and qualifies for maximum charitable gift deductions by individual donors.